Sánchez-Díaz Germán, Arias-Merino Greta, Villaverde-Hueso Ana, Morales-Piga Antonio, Abaitua-Borda Ignacio, Hens Manuel, Bermejo-Sánchez Eva, Posada de la Paz Manuel, Alonso-Ferreira Verónica
Institute of Rare Diseases Research, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Neuroepidemiology. 2016;47(3-4):155-163. doi: 10.1159/000452860. Epub 2016 Nov 25.
Huntington's disease (HD) is a progressive neurodegenerative condition characterized by chorea, dystonia, behavioral disturbances and cognitive decline. The aim of this study is to assess temporal and spatial changes on mortality attributable to HD over 30 years in Spain.
HD data were extracted from the nationwide mortality registry for the period 1984-2013. Annual and 5-year gender- and age-specific rates adjusted for the standard European population were calculated. Geographic analysis was performed by districts from 1999 through 2013, and then estimated standardized mortality ratios (SMRs) and smoothed SMRs.
There were 1,556 HD-related deaths across the study period. An increasing trend in age-adjusted HD mortality was in evidence, specifically from 1994 through 1998. On a year-by-year basis, age-adjusted mortality rates increased from 0.076 per 100,000 population in 1984 to 0.157 in 2013. Geographical differences among districts were evident in specific areas and in the southwest of Spain with a significantly higher HD mortality risk.
HD mortality rising trends in Spain might be attributable to improvements in diagnosis leading to a rise in prevalence. Geographical variability in HD mortality could be related to regional differences in disease prevalence, health-care disparities, or other factors which call for in-depth assessment in future studies.
亨廷顿舞蹈症(HD)是一种进行性神经退行性疾病,其特征为舞蹈症、肌张力障碍、行为障碍和认知衰退。本研究旨在评估西班牙30年间HD所致死亡率的时空变化。
从1984 - 2013年全国死亡率登记处提取HD数据。计算经欧洲标准人口调整后的年度和5年性别及年龄特异性死亡率。1999年至2013年按地区进行地理分析,然后估计标准化死亡率(SMR)和平滑SMR。
研究期间共有1556例与HD相关的死亡。年龄调整后的HD死亡率呈上升趋势,特别是在1994年至1998年期间。逐年来看,年龄调整后的死亡率从1984年的每10万人0.076例增至2013年的0.157例。各地区之间的地理差异在特定地区和西班牙西南部很明显,HD死亡风险显著更高。
西班牙HD死亡率上升趋势可能归因于诊断改善导致患病率上升。HD死亡率的地理差异可能与疾病患病率的地区差异、医疗保健差距或其他因素有关,这些因素需要在未来研究中进行深入评估。